galantamine has been researched along with isomethyleugenol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachus, R; Bickel, U; Kewitz, H; Roots, I; Thomsen, T | 1 |
1 trial(s) available for galantamine and isomethyleugenol
| Article | Year |
|---|---|
The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6.
Topics: Acetylcholinesterase; Adult; Butyrylcholinesterase; Catalysis; Cholinesterase Inhibitors; Cytochrome P-450 CYP2D6; Galantamine; Humans; In Vitro Techniques; Male; Methylation; Microsomes, Liver; Nootropic Agents; Reference Values | 1999 |